DCGI Frames Rules For Safety, Quality Of Imported Cosmetics

New Delhi:  No cosmetics can be imported unless the ‘use-by’ date is at least six months from the date of import, the Drugs Controller General of India (DCGI) said.

The regulator, issuing instructions for importing cosmetics, also banned imports of cosmetics containing hexachlorophene and those that have been tested on animals after 12 November 2014.

DCGI banned animal testing for makeup products and manufacturers and importers on that day.

Hexachlorophene is a topical antibacterial cleanser, used to clean the skin before surgery to prevent the spread of infection. It is banned for cosmetic use.

“No cosmetic, the manufacture, sale or distribution of which is prohibited in the country of origin, shall be imported under the same name or under any other name except for the purpose of examination, test or analysis,” the guidance document for zonal, sub-zonal and port offices stated.

According to industry estimates, India’s cosmetic market was valued at $8.1 billion in 2023 and is expected to reach $18.4 billion by 2032.

It said that any person who intends to import a new cosmetic needs to apply to the Central Licensing Authority with data on safety and effectiveness of the cosmetic.

Notably, beauty cosmetic items are mostly expensive and come in different domestic and international brands. In India, a large number of fake cosmetic items are sold in flea markets or by unauthorized sellers at a cheaper price.

According to the Cosmetic Rules, 2020, no cosmetic may convey any idea which is false or misleading to the intended user.

Earlier, Mint reported that DCGI has issued a new code for drug inspectors to make their inspections, sample collections and permits uniform, predictable and accountable.

It directed drug inspectors to follow a uniform drug sampling method and focus on identifying risks during selection of sample drugs, cosmetics and medical devices moving in the supply chain.

Related Posts

Zydus Lifesciences Q4FY26 net profit rises 9%

Zydus board approved a buyback of up to Rs 1100 crore at Rs 1,150 per share, along with a 100 percent dividend for FY26. Zydus Lifesciences reported a rise in…

Chemists strike on May 20: Reasons behind today’s all-India strike

While major pharmacy chains and government medical outlets will remain operational, the strike highlights significant tensions within the industry that could impact access to medications nationwide. The All India Organisation…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Zydus Lifesciences Q4FY26 net profit rises 9%

Zydus Lifesciences Q4FY26 net profit rises 9%

Chemists strike on May 20: Reasons behind today’s all-India strike

Chemists strike on May 20: Reasons behind today’s all-India strike

AbbVie loses patent plea for Hep C drug

AbbVie loses patent plea for Hep C drug

GSK’s Calpol a well-known trademark: High Court

GSK’s Calpol a well-known trademark: High Court

3 arrested for allegedly posing as doctors using forged MBBS degrees

3 arrested for allegedly posing as doctors using forged MBBS degrees

Commissioner FDA reviews enforcement measures

Commissioner FDA reviews enforcement measures